Your User Name is:
Saturday, October 20, 2018 1:30 p.m. - 3:00 p.m. Session I – Oropharynx - eContouring for Head and Neck Cancer I Dr. Sue Yom, Dr. Tabassum Kennedy, Dr. Andrew BayleyContour Homework:CTV_High on slices 85, 98, 103, 118CTV_Mid on slices 103CTV_Low on slices 85, 98, 103, 118Musc_Constrict_I on slices 118Enabled Contours for reference: GTVnDisabled Contours: All othersResource Files: AB Unknown Primary ASTRO 2018 VignetteDemo Training Video: How to contour, complete the homework, and save/submitEduCase User Guide
Saturday, October 20, 2018, 4:00 p.m. - 5:30 p.m. Session II – Non-oropharynx - eContouring for Head and Neck Cancer II Dr. Sue Yom, Dr. Tabassum Kennedy, Dr. Andrew BayleyContour Homework:GTVp on slices 125, 136, 143CTV_High on slices 125, 136, 143CTV_Low on slices 117, 125, 136, 143Enabled Contours for reference: NoneDisabled Contours: AllResource Files: AB Larynx for ASTRO 2018 Vignette Demo Training Video: How to contour, complete the homework, and save/submitEduCase User Guide
Sunday, September 24, 2017, 4:45 p.m. - 6:15 p.m. eContouring for Head and Neck Course II: Matthew Stenmark, MD, Sue Yom, MD, Suresh Mukherji, MD, MBA, FACRHomework:The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT, PET-CT, and MR).Assuming a 35 fraction treatment regimen with concurrent platinum-based chemotherapy, please use the treatment planning CT to define:Clinical target volumes, selecting from the following dose levels. You may use as many or as few as you see appropriate.CTV_70 Gy (2.0 Gy/fx)CTV_63 Gy (1.8 Gy/fx)CTV_59.5 Gy (1.7 Gy/fx)CTV_56 Gy (1.6 Gy/fx)Organs at risk, including the pharyngeal constrictor muscles and the brachial plexusContour as many or as few as you see appropriate on slices: 76, 80, 84, 88, 92, 96, 100, 104, 108, 112, 116(homework not engaged in UI)Enabled Reference Contours: GTVsDisabled Contours: All Except for GTVsResource Files:T3N2c supraglottic sqcca VignetteEduCase User Guide